SoylentNews

Mylan EpiPen Recall Expanded

posted by on Sunday April 02 2017, @10:27PM   
from the it-got-my-adrenaline-pumping dept.

An Anonymous Coward writes:

A recall for EpiPens will now extend to Asia, Europe, North America, and South America:

Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.

The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies.

[Ed. Note: This recall is limited to some lot numbers distributed in late 2015 and early-to-mid 2016. More information at the US FDA website.]

---

Original Submission

• Re:Why does no one make a generic 1980s style EpiP Re:Why does no one make a generic 1980s style EpiP (Score: 0) by Anonymous Coward on Monday April 03 2017, @02:35PM (4 children)

  by Anonymous Coward on Monday April 03 2017, @02:35PM (#488200)

  Why no competitor? Small, limited market, and Mylan may implicitly threaten to price any new competitor out so it's not terribly tempting for new comers to come in.

  Parent

• Re:Why does no one make a generic 1980s style EpiP Re:Why does no one make a generic 1980s style EpiP (Score: 0) by Anonymous Coward on Monday April 03 2017, @03:25PM (3 children)

  by Anonymous Coward on Monday April 03 2017, @03:25PM (#488228)

  I don’t think it’s such a small, limited market given the billions of dollars Mylan makes every year from EpiPen sales. They have a 95% share of the market of around 3.6 million Americans (around 1% of the total population) who have been prescribed epinephrine autoinjectors, which translates to at least $2 billion in sales per year at their price point of $600, at a profit of about $1.8 billion since an EpiPen only costs Mylan $35 to make. With 95% of the market, no one can deny that they are a monopoly, and if they tried to price any upcoming competitor out of the market, they’d be guilty of predatory pricing and run afoul of antitrust law as a result.

  Parent

  • Re:Why does no one make a generic 1980s style EpiP (Score: 2) by bob_super on Monday April 03 2017, @05:13PM

    by bob_super (1357) on Monday April 03 2017, @05:13PM (#488270)

    > run afoul of antitrust law as a result

    Quake in your boots! A couple blue state AGs may start hinting at a decades-long process which might potentially result in a minor slap on the wrist!

    Parent

  • Monopoly is not illegal Monopoly is not illegal (Score: 0) by Anonymous Coward on Monday April 03 2017, @05:46PM (1 child)

    by Anonymous Coward on Monday April 03 2017, @05:46PM (#488278)

    Being a monopoly is not a criminal offense, collusion/market power abuse is.

    Parent

    • Re:Monopoly is not illegal (Score: 0) by Anonymous Coward on Tuesday April 04 2017, @01:23AM

      by Anonymous Coward on Tuesday April 04 2017, @01:23AM (#488472)

      No, monopolies aren’t illegal. But if you’re a monopoly and use that position to try to shut potential competitors out of the market, that is market power abuse. One example of market power abuse is by attempting to price competitors out of the market, as the GGP says Mylan could potentially do to other pharmaceutical companies trying to market the old EpiPen design.

      Parent